-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EPuc/mDCjqoBNwkIvUVwJF2iQdWqjyDHgrrrBTP9Qq2UGG87u9RjTyLROzEN+8cP kJHgJkIclv6muI4hYBT15g== 0000874015-08-000021.txt : 20080411 0000874015-08-000021.hdr.sgml : 20080411 20080411185252 ACCESSION NUMBER: 0000874015-08-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080410 FILED AS OF DATE: 20080411 DATE AS OF CHANGE: 20080411 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ECKER DAVID J CENTRAL INDEX KEY: 0001073388 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 08753268 BUSINESS ADDRESS: BUSINESS PHONE: 760-931-9200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2008-04-10 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001073388 ECKER DAVID J C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD CARLSBAD CA 92008 0 1 0 0 Vice President Common Stock 2008-04-10 2008-04-10 4 M 0 5300 6.84 A 5300 D Common Stock 2008-04-10 2008-04-10 4 S 0 5300 16.042 D 0 D Common Stock 30213 I By Trust Employee Stock Option (right to buy) 6.84 2008-04-10 2008-04-10 4 M 0 5300 0 D 2007-01-02 2013-01-01 Common Stock 5300 0 D The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 1/31/08. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 1/31/08. /s/Stanley T. Crooke, Attorney-in-Fact 2008-04-11 -----END PRIVACY-ENHANCED MESSAGE-----